Hillsborough, NJ, United States of America

Jing Tao

This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Abbvie Deutschland Gmbh and Co Kg, Abbvie Inc., Wisconsin Alumni Research Foundation. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jing Tao. Retrieved from https://idiyas.com/inventor/jing-tao-dkj37d1o

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Jing Tao in Pharmaceutical Formulations.

Introduction

Jing Tao is an inventor based in the United States, known for his contributions to the field of pharmaceutical formulations. His work focuses on enhancing the bioavailability of poorly soluble drugs through innovative methods.

Latest Patents

Jing Tao has developed a method titled "Method For Evaluating The Solubility Of A Crystalline Substance In A Polymer." This invention addresses the challenge of using amorphous solids in place of crystalline solids in drug formulations. The method utilizes Differential Scanning Calorimetry (DSC) to measure the solubility of crystalline drugs in polymeric matrices, providing a solution to the difficulties posed by high viscosity and structural relaxation in drug/polymer dispersions.

Career Highlights

Throughout his career, Jing Tao has worked with notable companies such as AbbVie Deutschland GmbH and Co. KG and AbbVie Inc. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Jing Tao has collaborated with professionals like Geoff G. Zhang and Lian Yu, who have played significant roles in his research endeavors.

Conclusion

Jing Tao's innovative methods in evaluating drug solubility in polymers represent a significant advancement in pharmaceutical science. His contributions are poised to enhance the effectiveness of drug formulations and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…